Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Long-acting GLP-1 analogue shows promise in diabetic mice

Sep. 30, 2013

Cadila Healthcare divulges discovery of PCSK9 inhibitors

Sep. 27, 2013

Novo Nordisk files application to expand approval of liraglutide in Japan

Sep. 27, 2013

Gemigliptin is safe and efficient as a long-term treatment added to ongoing metformin

Sep. 27, 2013

Torrent Pharmaceuticals presents first clinical data for TRC-150094

Sep. 27, 2013

Weekly and monthly regimens of langlenatide well tolerated in phase IIa study

Sep. 26, 2013

Quartette launched in U.S.

Sep. 26, 2013

BioLineRx files to initiate phase I/II celiac disease study in Finland

Sep. 26, 2013

Takeda obtains European approval for three new type 2 diabetes therapies

Sep. 25, 2013

Isis Pharmaceuticals reports phase II ISIS-APOCIIIRx data in familial chylomicronemia

Sep. 25, 2013

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...